AstraZeneca announces layoffs in Spain to reduce its workforce of almost 2,000 employees
Article excerpt
Highlighted: the sentence this signal was extracted from
Pharmaceutical company AstraZeneca, one of the companies that garnered the most headlines during the pandemic for the development of one of the vaccines against COVID, is preparing a layoff process in Spain, which will affect multiple workers. Currently, its workforce is close to 2,000 employees.The company has internally referred to the process as a "layoff file," although in internal communications the workforce already identifies it as an Employment Regulation File (ERE), pending formal knowledge of its scope and characteristics. "We periodically review our resources to adapt them to our constantly evolving product portfolio," it acknowledged when questioned by this media outlet. According to ElConfidencial, a pre-notification has been sent to workers' representatives, and the first meeting of the negotiation table has been set for next October 13. From that date, a thirty-day negotiation period will formally open between the company and the workforce representatives. It will then be when AstraZeneca must present the reasons for the file, the number of affected individuals, and the areas on which it intends to focus the adjustment. For now, workers are unaware of both the final scope of the cut and which specific positions will be affected.According to the accounts of AstraZeneca Farmacéutica Spain, corresponding to 2025 and deposited in the Commercial Registry, the...
Keep reading with a free account
The rest of this article, and every signal for AstraZeneca, is in your free account.
:format(jpg):quality(99):watermark(f.elconfidencial.com/file/65c/43d/0ca/65c43d0ca5dbd5ff8f19b44167343db9.png,0,275,1)/f.elconfidencial.com/original/a44/42c/822/a4442c822df3c0376acee250febdc488.jpg)